FIELD: chemistry.
SUBSTANCE: in formula (I) each of A1, A2 and A3 is independently selected from the group, consisting of O and S, R1 represents an alkyl chain with the length of 2-28 carbon atoms, R2 is selected from the group, consisting of (3-carboxy)propyl and (20carboxy)ethyl, and R3 is selected from the group, consisting of H, C1-20acyl, phosphate, phosphocholine, phosphoethanolamine, phosphoethanolamine-N-glutaric acid and phosphoserine. The invention also relates to a pharmaceutical composition, containing the said compounds, and to the application of the compounds for manufacturing a medication, intended for treatment or prevention of diseases or disorders, associated with inflammation, or for the reduction of the level of cytokine, selected from the group, consisting of interleukin-12 and interleukin-23.
EFFECT: increase of the treatment efficiency.
60 cl, 39 dwg, 18 ex
Title | Year | Author | Number |
---|---|---|---|
OXIDISED LIPIDS AND THEIR APPLICATION FOR TREATMENT OF INFLAMMATORY DISEASES AND DISTURBANCES | 2004 |
|
RU2362567C2 |
OXIDISED LIPIDES AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES AND DISORDERS | 2009 |
|
RU2482854C2 |
IMPROVED METHOD FOR SYNTHESIS OF OXIDISED PHOSPHOLIPIDS | 2005 |
|
RU2399626C2 |
METHOD OF PRODUCING TRIPHENYLMETHYL DERIVATIVES OF SN-GLYCERO-3-PHOSPHOCHOLINE AND SN-GLYCERO-3 PHOSPHO-ETHANOLAMINE | 0 |
|
SU1422999A3 |
METHOD OF PRODUCING DERIVATIVES OF GLYCEROPHOSPHOLIPINS | 0 |
|
SU1400511A3 |
METHOD OF OBTAINING 1-ALKYL-2-ALKYLCARBAMOYL GLYCERINE | 2016 |
|
RU2621347C1 |
METHOD OF PRODUCING MODIFIED MAGNETITE CRYSTALS | 2018 |
|
RU2689392C1 |
METHOD FOR OBTAINING SUPRAMOLECULAR PLATINUM COMPOUNDS | 2016 |
|
RU2795256C2 |
COMPOUNDS BASED ON PLATINUM AND LIPIDS AND NANOPARTICLES | 2014 |
|
RU2737735C2 |
LIPID COMPOUND AND COMPOSITION BASED THEREON | 2021 |
|
RU2825571C1 |
Authors
Dates
2014-11-10—Published
2009-11-05—Filed